Q3 2025 Earnings Call Transcript October 27, 2025 BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS ...
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It announced today ...
Background Stillbirth rates remain unacceptably high in low- and middle-income countries (LMICs). Understanding the causes of ...
Objective Interstitial lung disease (ILD) represents the most common and severe organ manifestation observed in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback